MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,972,000 | -72.5% | 450,000 | -77.5% | 0.86% | -73.6% |
| Q1 2020 | $54,400,000 | -15.2% | 2,000,000 | -38.5% | 3.25% | -0.5% |
| Q4 2019 | $64,123,000 | +41.4% | 3,250,000 | -7.1% | 3.26% | +36.8% |
| Q3 2019 | $45,360,000 | +4.1% | 3,500,000 | 0.0% | 2.38% | +17.4% |
| Q2 2019 | $43,575,000 | -25.0% | 3,500,000 | -12.5% | 2.03% | -29.9% |
| Q1 2019 | $58,120,000 | +31.6% | 4,000,000 | 0.0% | 2.90% | +38.2% |
| Q4 2018 | $44,160,000 | -41.7% | 4,000,000 | +38.9% | 2.10% | -35.3% |
| Q3 2018 | $75,715,000 | +21.2% | 2,878,890 | -5.8% | 3.24% | +34.8% |
| Q2 2018 | $62,475,000 | +2443.8% | 3,055,000 | +2157.9% | 2.40% | +1886.8% |
| Q1 2018 | $2,456,000 | -47.3% | 135,300 | -66.2% | 0.12% | -66.8% |
| Q1 2014 | $4,660,000 | -67.1% | 400,000 | -50.0% | 0.36% | -70.8% |
| Q4 2013 | $14,144,000 | +22.9% | 800,000 | 0.0% | 1.25% | +3.4% |
| Q3 2013 | $11,512,000 | -4.4% | 800,000 | 0.0% | 1.21% | -2.6% |
| Q2 2013 | $12,048,000 | – | 800,000 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
| Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
| Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
| Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
| Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
| Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
| RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
| MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
| Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
| PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |